Cereno Scientific Strengthens Patent Protection for CS1 with First Granted Patent in the Third Patent Family

Cereno Scientific announced that intellectual property rights (IPR) for drug candidate CS1's third patent family has been granted in Russia. This is the first patent grant in the third patent family, adding to Cereno's extensive patent protection across nearly all global key markets.